{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:35:13Z","timestamp":1785886513376,"version":"3.56.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Recent progress in single-cell profiling technologies has revealed significant phenotypic and transcriptional heterogeneity in tumor-infiltrating CD8+ T cells. However, the transition between the different states of intratumoral antigen-specific CD8+ T cells remains elusive. Here, we sought to examine the generation, transcriptomic states, and the clinical relevance of melanoma-infiltrating CD8+ T cells expressing a chemokine receptor and T-cell differentiation marker, CX3C chemokine receptor 1 (CX3CR1). Analysis of single-cell datasets revealed distinct human melanoma-infiltrating CD8+ T-cell clusters expressing genes associated with effector T-cell function but with distinguishing expression of CX3CR1 or PDCD1. No obvious impact of CX3CR1 expression in melanoma on the response to immune checkpoint inhibitor therapy was observed while increased pretreatment and on-treatment frequency of a CD8+ T-cell cluster expressing high levels of exhaustion markers was associated with poor response to the treatment. Adoptively transferred antigen-specific CX3CR1\u2212 CD8+ T cells differentiated into the CX3CR1+ subset in mice treated with FTY720, which inhibits lymphocyte egress from secondary lymphoid tissues, suggesting the intratumoral generation of CX3CR1+ CD8+ T cells rather than their trafficking from secondary lymphoid organs. Furthermore, analysis of adoptively transferred antigen-specific CD8+ T cells, in which the Cx3cr1 gene was replaced with a marker gene confirmed that CX3CR1+ CD8+ T cells could directly differentiate from the intratumoral CX3CR1\u2212 subset. These findings highlight that tumor antigen\u2013specific CX3CR1\u2212 CD8+ T cells can fully differentiate outside the secondary lymphoid organs and generate CX3CR1+ CD8+ T cells in the tumor microenvironment, which are distinct from CD8+ T cells that express markers of exhaustion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Intratumoral T cells are composed of heterogeneous subpopulations with various phenotypic and transcriptional states. This study illustrates the intratumoral generation of antigen-specific CX3CR1+ CD8+ T cells that exhibit distinct transcriptomic signatures and clinical relevance from CD8+ T cells expressing markers of exhaustion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0199","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T01:59:50Z","timestamp":1718589590000},"page":"1802-1814","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5249-8598","authenticated-orcid":false,"given":"Hirohito","family":"Ishigaki","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California. 1"},{"name":"Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-7658","authenticated-orcid":false,"given":"Takayoshi","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California. 1"},{"name":"Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-8176","authenticated-orcid":false,"given":"Mark D.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8853-4167","authenticated-orcid":false,"given":"Toshifumi","family":"Hoki","sequence":"additional","affiliation":[{"name":"Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 3"},{"name":"Oncology Science Unit, MSD Japan, Tokyo, Japan. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1225-2240","authenticated-orcid":false,"given":"Yuta","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California. 1"},{"name":"Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-4989","authenticated-orcid":false,"given":"Takaaki","family":"Oba","sequence":"additional","affiliation":[{"name":"Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 3"},{"name":"Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-671X","authenticated-orcid":false,"given":"Fumito","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California. 1"},{"name":"Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"2025032818083355100_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"2025032818083355100_bib2","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2025032818083355100_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2013.07.002","article-title":"Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology","volume":"39","author":"Kalos","year":"2013","journal-title":"Immunity"},{"key":"2025032818083355100_bib4","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1158\/1078-0432.CCR-10-1297","article-title":"CD8+ enriched [L8D2Q2M0]young[R8D2Q2M1] tumor infiltrating lymphocytes can mediate regression of metastatic melanoma","volume":"16","author":"Dudley","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2025032818083355100_bib5","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1158\/1078-0432.CCR-11-0503","article-title":"Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice","volume":"17","author":"Klebanoff","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2025032818083355100_bib6","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"Gattinoni","year":"2005","journal-title":"J Clin Invest"},{"key":"2025032818083355100_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2025032818083355100_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nri3740","article-title":"T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?","volume":"14","author":"Speiser","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2025032818083355100_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"2025032818083355100_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining [L8S2Q1M6]T cell exhaustion[R8S2Q1M7]","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2025032818083355100_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"2025032818083355100_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"2025032818083355100_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7150\/jca.47022","article-title":"Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: a mini-review","volume":"12","author":"Rivas-Fuentes","year":"2021","journal-title":"J Cancer"},{"key":"2025032818083355100_bib14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"2025032818083355100_bib15","doi-asserted-by":"crossref","first-page":"e133920","DOI":"10.1172\/jci.insight.133920","article-title":"CX3CR1-CD8+ T cells are critical in antitumor efficacy, but functionally suppressed in the tumor microenvironment","volume":"5","author":"Yamauchi","year":"2020","journal-title":"JCI insight"},{"key":"2025032818083355100_bib16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-021-21619-0","article-title":"T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors","volume":"12","author":"Yamauchi","year":"2021","journal-title":"Nat Commun"},{"key":"2025032818083355100_bib17","doi-asserted-by":"crossref","first-page":"e97828","DOI":"10.1172\/jci.insight.97828","article-title":"CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy","volume":"3","author":"Yan","year":"2018","journal-title":"JCI insight"},{"key":"2025032818083355100_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/2767-9764.CRC-22-0383","article-title":"Predictive and prognostic implications of circulating CX3CR1+ CD8+ T cells in non-small cell lung cancer patients treated with chemo-immunotherapy","volume":"3","author":"Abdelfatah","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025032818083355100_bib19","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-21-0939","article-title":"Neoadjuvant in situ immunomodulation enhances systemic antitumor immunity against highly metastatic tumors","volume":"81","author":"Oba","year":"2021","journal-title":"Cancer Res"},{"key":"2025032818083355100_bib20","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-020-19192-z","article-title":"Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s","volume":"11","author":"Oba","year":"2020","journal-title":"Nat Commun"},{"key":"2025032818083355100_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00262-021-02969-6","article-title":"CD40 and CD80\/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells","volume":"71","author":"Yamauchi","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"2025032818083355100_bib22","doi-asserted-by":"crossref","first-page":"21992","DOI":"10.1038\/s41598-021-01455-4","article-title":"Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer","volume":"11","author":"Yokoi","year":"2021","journal-title":"Sci Rep"},{"key":"2025032818083355100_bib23","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4049\/jimmunol.2000347","article-title":"A critical role of CD40 and CD70 signaling in conventional type 1 dendritic cells in expansion and antitumor efficacy of adoptively transferred tumor-specific T cells","volume":"205","author":"Oba","year":"2020","journal-title":"J Immunol"},{"key":"2025032818083355100_bib24","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1158\/0008-5472.CAN-15-1742","article-title":"Adoptive transfer of CD8+ T cells generated from induced pluripotent stem cells triggers regressions of large tumors along with immunological memory","volume":"76","author":"Saito","year":"2016","journal-title":"Cancer Res"},{"key":"2025032818083355100_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2025032818083355100_bib26","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2025032818083355100_bib27","doi-asserted-by":"crossref","first-page":"e003827","DOI":"10.1136\/jitc-2021-003827","article-title":"Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling","volume":"10","author":"Makino","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025032818083355100_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"key":"2025032818083355100_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J Exp Med"},{"key":"2025032818083355100_bib30","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/eji.200526042","article-title":"Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells","volume":"35","author":"Xin","year":"2005","journal-title":"Eur J Immunol"},{"key":"2025032818083355100_bib31","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/ncomms8458","article-title":"Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints","volume":"6","author":"Mikucki","year":"2015","journal-title":"Nat Commun"},{"key":"2025032818083355100_bib32","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing","volume":"160","author":"Chiba","year":"1998","journal-title":"J Immunol"},{"key":"2025032818083355100_bib33","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.4049\/jimmunol.164.11.5761","article-title":"FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory","volume":"164","author":"Pinschewer","year":"2000","journal-title":"J Immunol"},{"key":"2025032818083355100_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"2025032818083355100_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: defining mechanisms of T cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol"},{"key":"2025032818083355100_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2025032818083355100_bib37","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1128\/JVI.00889-12","article-title":"Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection","volume":"86","author":"Angelosanto","year":"2012","journal-title":"J Virol"},{"key":"2025032818083355100_bib38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"key":"2025032818083355100_bib39","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","article-title":"CD4+ T cell help confers a cytotoxic T cell effector Program including coinhibitory receptor downregulation and increased tissue invasiveness","volume":"47","author":"Ahrends","year":"2017","journal-title":"Immunity"},{"key":"2025032818083355100_bib40","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ijc.22660","article-title":"Defective antitumor responses in CX3CR1-deficient mice","volume":"121","author":"Yu","year":"2007","journal-title":"Int J Cancer"},{"key":"2025032818083355100_bib41","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/0008-5472.CAN-06-3041","article-title":"Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells","volume":"67","author":"Zeng","year":"2007","journal-title":"Cancer Res"},{"key":"2025032818083355100_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"2025032818083355100_bib43","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20062363","article-title":"Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses","volume":"204","author":"Precopio","year":"2007","journal-title":"J Exp Med"},{"key":"2025032818083355100_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1074-7613(00)80102-8","article-title":"Interleukin-2 expression by a subpopulation of primary T cells is linked to enhanced memory\/effector function","volume":"11","author":"Saparov","year":"1999","journal-title":"Immunity"},{"key":"2025032818083355100_bib45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"2025032818083355100_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"2025032818083355100_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1126\/science.1185837","article-title":"Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21","volume":"328","author":"Shields","year":"2010","journal-title":"Science"},{"key":"2025032818083355100_bib48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijc.10816","article-title":"Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells","volume":"103","author":"Guo","year":"2003","journal-title":"Int J Cancer"},{"key":"2025032818083355100_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/mco.2012.30","article-title":"Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo","volume":"1","author":"Kee","year":"2013","journal-title":"Mol Clin Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0199\/3462637\/crc-24-0199.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/7\/1802\/3501205\/crc-24-0199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/7\/1802\/3501205\/crc-24-0199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:16:16Z","timestamp":1743189376000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/7\/1802\/746671\/Generation-Transcriptomic-States-and-Clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0199","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.26363340","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363349.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118393","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363322","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363334","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118387","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363346","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688733","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688721","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688739","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363343.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688727","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363337.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363340.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363328","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363346.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118390","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118396","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118384","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363331.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363331","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118378","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363343","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363328.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363325.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363334.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688730","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688724","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688736","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363322.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363325","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363337","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363349","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363319.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27118381","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26363319","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7363977","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7363977.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}